S446-0014 Screening compound: N~1~-(3,4-dimethoxyphenethyl)-2-(1-oxo-1,7,8,9,10,11-hexahydro-2H-cyclohepta[3,4]pyrazolo[1,5-a]pyrazin-2-yl)acetamide

S446-0014 Screening compound: N~1~-(3,4-dimethoxyphenethyl)-2-(1-oxo-1,7,8,9,10,11-hexahydro-2H-cyclohepta[3,4]pyrazolo[1,5-a]pyrazin-2-yl)acetamide
S446-0014 Screening compound: N~1~-(3,4-dimethoxyphenethyl)-2-(1-oxo-1,7,8,9,10,11-hexahydro-2H-cyclohepta[3,4]pyrazolo[1,5-a]pyrazin-2-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S446-0014
N~1~-(3,4-dimethoxyphenethyl)-2-(1-oxo-1,7,8,9,10,11-hexahydro-2H-cyclohepta[3,4]pyrazolo[1,5-a]pyrazin-2-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S446-0014

Molecular Formula

C23H28N4O4 (C23 H28 N4 O4)

Compound Name

N~1~-(3,4-dimethoxyphenethyl)-2-(1-oxo-1,7,8,9,10,11-hexahydro-2H-cyclohepta[3,4]pyrazolo[1,5-a]pyrazin-2-yl)acetamide

IUPAC name

N-[2-(34-dimethoxyphenyl)ethyl]-2-{3-oxo-478-triazatricyclo[7.5.0.0^{27}]tetradeca-158-trien-4-yl}acetamide

SMILES

COc(ccc(CCNC(CN(C=Cn1nc(CCCCC2)c2c11)C1=O)=O)c1)c1OC

InChI

InChI=1S/C23H28N4O4/c1-30-19-9-8-16(14-20(19)31-2)10-11-24-21(28)15-26-12-13-27-22(23(26)29)17-6-4-3-5-7-18(17)25-27/h8-9,12-14H,3-7,10-11,15H2,1-2H3,(H,24,28)

InChI Key

UFURLXZOJCZPTN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29006039

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

424.5

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.970

Distribution Coefficient, logD

0.970

Water Solubility, LogSw

-2.12

Polar Surface Area

69.344

Acid Dissociation Constant (pKa)

14.68

Base Dissociation Constant (pKb)

0.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.50

S446-0014 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S446-0014 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S446-0014?
Check Price and Availability of S446-0014, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S446-0014 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S446-0014
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S446-0014
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S446-0014 available by request